Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder

International Journal of Urology : Official Journal of the Japanese Urological Association
Yoshinori TanakaTaiji Tsukamoto

Abstract

To investigate the urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder (OAB). A total of 52 untreated female patients with OAB symptoms were given 5 mg solifenacin once daily for 12 weeks. Before and after treatment, the frequency volume chart, overactive bladder symptom score (OABSS), postvoid residual volume, filling cystometry and adverse events were evaluated. After solifenacin treatment, OAB symptoms were improved, voided volume was increased and voiding number was decreased. Bladder capacities at the first sensation of bladder filling, first desire to void and strong desire to void were significantly increased. Intravesical pressure at the first sensation of bladder filling was significantly decreased. Detrusor overactivity (DO) disappeared in five patients. For 28 patients with persisting DO after treatment, bladder capacity at DO was significantly increased. Both groups with and without DO at baseline had significant improvements of OAB symptoms. Solifenacin urodynamically increases bladder capacity in female patients with symptomatic OAB.

References

Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Jul 18, 2002·Naunyn-Schmiedeberg's Archives of Pharmacology·Ken IkedaKazuo Honda
Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
Apr 9, 2005·European Journal of Pharmacology·Masanori SuzukiMasao Sasamata
Nov 17, 2005·BJU International·Yukio HommaUNKNOWN Neurogenic Bladder Society Committee
Aug 1, 2007·Neurourology and Urodynamics·Osamu YamaguchiMasaki Yoshida

❮ Previous
Next ❯

Citations

Nov 17, 2011·International Neurourology Journal·Seong Jin JeongSeung-June Oh
Oct 23, 2014·International Urogynecology Journal·Jacquia F De La CruzElizabeth J Geller
Dec 7, 2013·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Stephanie Oger-RousselFrancois Giuliano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.